208 related articles for article (PubMed ID: 10469435)
1. Intracranial gliomas in neurofibromatosis type 1.
Listernick R; Charrow J; Gutmann DH
Am J Med Genet; 1999 Mar; 89(1):38-44. PubMed ID: 10469435
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
3. Optic Gliomas in Neurofibromatosis Type 1.
Parkhurst E; Abboy S
J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
[TBL] [Abstract][Full Text] [Related]
4. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome in children with gliomas of the anterior visual pathway.
Tow SL; Chandela S; Miller NR; Avellino AM
Pediatr Neurol; 2003 Apr; 28(4):262-70. PubMed ID: 12849878
[TBL] [Abstract][Full Text] [Related]
6. Intracranial neoplasms in children with neurofibromatosis 1.
Rosser T; Packer RJ
J Child Neurol; 2002 Aug; 17(8):630-7; discussion 646-51. PubMed ID: 12403562
[TBL] [Abstract][Full Text] [Related]
7. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
Cnossen MH; Stam EN; Cooiman LC; Simonsz HJ; Stroink H; Oranje AP; Halley DJ; de Goede-Bolder A; Niermeijer MF; de Muinck Keizer-Schrama SM
Pediatrics; 1997 Oct; 100(4):667-70. PubMed ID: 9310522
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1.
Mahdi J; Shah AC; Sato A; Morris SM; McKinstry RC; Listernick R; Packer RJ; Fisher MJ; Gutmann DH
Neurology; 2017 Apr; 88(16):1584-1589. PubMed ID: 28330960
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
[TBL] [Abstract][Full Text] [Related]
10. Growth and pubertal disorders in neurofibromatosis type 1.
Virdis R; Street ME; Bandello MA; Tripodi C; Donadio A; Villani AR; Cagozzi L; Garavelli L; Bernasconi S
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():289-92. PubMed ID: 12729406
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M
Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
[TBL] [Abstract][Full Text] [Related]
12. Brainstem glioma presenting as pruritus in children with neurofibromatosis-1.
Darken RS; Bogitch R; Leonard J; Perry A; McKinstry RC; Gutmann DH; Rubin JB
J Pediatr Hematol Oncol; 2009 Dec; 31(12):972-6. PubMed ID: 19935099
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
Farmer JP; Khan S; Khan A; Ortenberg J; Freeman C; O'Gorman AM; Montes J
Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
[TBL] [Abstract][Full Text] [Related]
14. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.
North K; Cochineas C; Tang E; Fagan E
Pediatr Neurol; 1994 Mar; 10(2):117-23. PubMed ID: 8024659
[TBL] [Abstract][Full Text] [Related]
15. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
Kocova M; Kochova E; Sukarova-Angelovska E
BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
[TBL] [Abstract][Full Text] [Related]
16. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T; Pfister SM; Rood B; Rodriguez FJ; Tabori U; Ramaswamy V; Zhu Y; Fangusaro J; Johnston SA; Gutmann DH
Neuro Oncol; 2020 Jun; 22(6):773-784. PubMed ID: 32055852
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
[TBL] [Abstract][Full Text] [Related]
18. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1).
Gutmann DH; Rasmussen SA; Wolkenstein P; MacCollin MM; Guha A; Inskip PD; North KN; Poyhonen M; Birch PH; Friedman JM
Neurology; 2002 Sep; 59(5):759-61. PubMed ID: 12221173
[TBL] [Abstract][Full Text] [Related]
19. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.
Listernick R; Louis DN; Packer RJ; Gutmann DH
Ann Neurol; 1997 Feb; 41(2):143-9. PubMed ID: 9029062
[No Abstract] [Full Text] [Related]
20. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
Laue L; Comite F; Hench K; Loriaux DL; Cutler GB; Pescovitz OH
Am J Dis Child; 1985 Nov; 139(11):1097-100. PubMed ID: 3933329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
